[O-24] Neuroimmunology (Biomarker)

[O-24-3] Usefulness of proton MRS in differentiating tumefactive demyelinating lesions from gliomas

^○Ryotaro Ikeguchi¹, Yuko Shimizu¹, Kayoko Abe², Satoru Shimizu³, Takashi Maruyama⁴, Masayuki Nitta⁴, Koichiro Abe², Takakazu Kawamata⁴, Kazuo Kitagawa¹ (1.Department of Neurology, Tokyo Women's Medical University, 2.Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women's Medical University, 3.Medical research institute, Tokyo Women's Medical University, 4.Department of Neurosurgery, Tokyo Women's Medical University)